scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1470-2045(19)30340-7 |
P698 | PubMed publication ID | 31300207 |
P50 | author | Andreas Leimbach | Q55079381 |
Martin Widschwendter | Q71025350 | ||
P2093 | author name string | Allison Jones | |
Andy Ryan | |||
Susanne Knapp | |||
David Cibula | |||
Michal Zikan | |||
Nicoletta Colombo | |||
Nuno R Nené | |||
Line Bjørge | |||
John F Timms | |||
Dorella Franchi | |||
Tobias Paprotka | |||
Daniel Reisel | |||
Iona Evans | |||
Shohreh Ghazali | |||
P2860 | cites work | The vaginal microbiota: what have we learned after a decade of molecular characterization? | Q21131955 |
Basic local alignment search tool | Q25938991 | ||
Vaginal microbiome of reproductive-age women | Q28284755 | ||
The NCBI Taxonomy database | Q28740981 | ||
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences | Q29547172 | ||
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis | Q29547434 | ||
UCHIME improves sensitivity and speed of chimera detection | Q29547664 | ||
FLASH: fast length adjustment of short reads to improve genome assemblies | Q29615113 | ||
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls | Q31147531 | ||
The ovarian cancer oncobiome | Q33829460 | ||
Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer | Q34113283 | ||
Tubal ligation and the risk of ovarian cancer: review and meta-analysis | Q34126227 | ||
Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies | Q34397845 | ||
Cancer and the microbiota | Q34470083 | ||
Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection | Q34974847 | ||
Comparing High-throughput Platforms for Sequencing the V4 Region of SSU-rDNA in Environmental Microbial Eukaryotic Diversity Surveys | Q35329346 | ||
Potential contribution of the uterine microbiome in the development of endometrial cancer | Q37440393 | ||
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers | Q38717239 | ||
Cervicovaginal Microbiomes-Threats and Possibilities | Q38821130 | ||
Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. | Q39135146 | ||
The vaginal microbiota, host defence and reproductive physiology | Q40626998 | ||
The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases | Q42379632 | ||
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. | Q44946113 | ||
The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections | Q45233106 | ||
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study. | Q45802281 | ||
Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study | Q46609744 | ||
False discovery rate, sensitivity and sample size for microarray studies. | Q47384576 | ||
Ovarian cancer | Q54105461 | ||
The influence of ethnicity and geography on human gut microbiome composition | Q57059975 | ||
Regional variation limits applications of healthy gut microbiome reference ranges and disease models | Q58045721 | ||
Case for a role of the microbiome in gynecologic cancers: Clinician's perspective | Q90705676 | ||
Modulating the microbiome to improve therapeutic response in cancer | Q91321458 | ||
P433 | issue | 8 | |
P921 | main subject | ovarian cancer | Q172341 |
BRCA1 Mutation | Q28444960 | ||
P304 | page(s) | 1171-1182 | |
P577 | publication date | 2019-07-09 | |
P1433 | published in | Lancet Oncology Commission | Q13747613 |
P1476 | title | Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study | |
P478 | volume | 20 |
Q94585881 | An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping |
Q89975415 | Non-Surgical Cancer Risk Reduction in BRCA1 Mutation Carriers: Disabling the Remote Control |
Q91837168 | Of microbes and women: BRCA1, vaginal microbiota, and ovarian cancer |
Q90056668 | Opportunities and Challenges of the Human Microbiome in Ovarian Cancer |
Q97527176 | The Alterations of Vaginal Microbiome in HPV16 Infection as Identified by Shotgun Metagenomic Sequencing |
Q93237520 | Tissue-Specific Carcinogens as Soil to Seed BRCA1/2-Mutant Hereditary Cancers |
Q91713074 | Vaginal microbiomes and ovarian cancer: a review |
Search more.